@article{TLCR7988,
author = {Fergus Macbeth and Ben Carter and Simon Nobl Noble and Kerenza Hood},
title = {Further results of the FRAGMATIC trial of thromboprophylaxis in lung cancer},
journal = {Translational Lung Cancer Research},
volume = {5},
number = {3},
year = {2016},
keywords = {},
abstract = {The FRAGMATIC trial was a multi-centre, open-label study comparing the addition of a primary prophylactic daily dose of the low molecular weight heparin (LMWH), dalteparin, for 24 weeks to standard treatment in newly diagnosed lung cancer patients of any stage or histology (1).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/7988}
}